AR and prostate cancer: These cell lines are representative of various stages of prostate cancer including (i) early-stage with androgen sensitivity (LNCaP) (ii) advanced-stage with the loss of androgen receptor (AR) function (PC3 and DU145) and (iii) castration resistant prostate cancer harboring repressed AR (22Rv1).